Jeong Yong Jeon
Overview
Explore the profile of Jeong Yong Jeon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choi J, Jun M, Yong Jeon J, Kim H, Kim Y, Jeon C, et al.
J Transl Int Med
. 2023 Dec;
11(4):410-422.
PMID: 38130632
Objective: The objective of this study is to provide a comparative analysis of variant clusters and their relevance across Africa, America, Europe, and Asia, in order to understand the evolutionary...
2.
Kim D, Kim S, Ahn J, Kim J, Ma H, Seo D, et al.
Int J Med Microbiol
. 2020 Feb;
310(2):151391.
PMID: 32007342
Lactobacillus plantarum has been identified as a probiotic bacterium owing to its role in immune regulation and maintenance of intestinal permeability. Here, we investigated the anti-colitic effects and mechanism of...
3.
Bahk Y, Edmund Kim E, Chung Y, Park J, Yong Jeon J, Jeong H
J Int Med Res
. 2019 Jan;
47(4):1493-1503.
PMID: 30628519
Objective: To analyze the performance of sequential naïve pinhole bone scan (nPBS) and gamma correction pinhole bone scan (GCPBS), reinforced by ImageJ densitometry and pixelized microfracture measurement, for making specific...
4.
Choi K, Yong Jeon J, Lee Y, Kim S, Kim S, Yun Y, et al.
Transl Oncol
. 2018 Dec;
12(2):381-388.
PMID: 30522045
Advanced cancer has been shown to be associated with a higher percentage of epigenetic changes than with genetic mutations. Preclinical models have shown that the combination of paclitaxel, sorafenib, and...
5.
Park K, Kim S, Yong Jeon J, Jo A, Choi H, Kim J, et al.
Clin Cancer Res
. 2017 Dec;
24(7):1677-1690.
PMID: 29279319
Cancer cells grow in an unfavorable metabolic milieu in the tumor microenvironment and are constantly exposed to metabolic stress such as chronic nutrient depletion. Cancer stem-like cells (CSC) are intrinsically...
6.
Park K, Kim S, Yong Jeon J, Kim B, Kim H, Chang H, et al.
Neoplasia
. 2017 Jul;
19(8):660.
PMID: 28739012
No abstract available.
7.
Lee M, Yong Jeon J, Neugent M, Kim J, Yun M
Clin Exp Metastasis
. 2017 Apr;
34(3-4):251-260.
PMID: 28429188
Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer mortality worldwide. Several studies have investigated the relationship between F-fluorodeoxyglucose (F-FDG) uptake on positron emission tomography and the prognosis of...
8.
Yong Jeon J, Lee M, Whang S, Kim J, Cho A, Yun M
Oncol Res
. 2017 Apr;
26(1):71-81.
PMID: 28390113
Altered energy metabolism is a biochemical fingerprint of cancer cells. Hepatocellular carcinoma (HCC) shows reciprocal [18F]fluorodeoxyglucose (FDG) and [11C]acetate uptake, as revealed by positron emission tomography/computed tomography (PET/CT). Previous studies...
9.
Park K, Kim S, Yong Jeon J, Kim B, Kim H, Chang H, et al.
Neoplasia
. 2017 Feb;
19(3):145-153.
PMID: 28142087
Anaplastic thyroid carcinoma (ATC) although rare is the most deadly form of thyroid cancer. The fatality rate for ATC is high-pitched, the survival rate at 1 year after diagnosis is...
10.
Choi J, Lee J, Koh I, Shim J, Park J, Yong Jeon J, et al.
Oncotarget
. 2016 Sep;
7(40):65643-65659.
PMID: 27582539
Studies have investigated biguanide-derived agents for the treatment of cancers and have reported their effects against tumorspheres (TSs). The purpose of this study was determining the effects of HL156A, a...